Company profile: ProQinase
1.1 - Company Overview
Company description
- Provider of contract research services, founded in 2001 as a subsidiary of the Tumor Biology Center Freiburg. Originated to support the center’s in-house anti-cancer drug development by marketing research tools, with roots in a cancer center that combined research and patient care.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ProQinase
Explora BioLabs
HQ: United States
Website
- Description: Provider of preclinical, AAALAC-accredited vivarium rental facilities and contract vivarium operation services, delivering turnkey in vivo facilities, management, and related services for biopharmaceutical clients in biotech-dense areas, with vivarium management ensuring maintenance and compliance and CRO options to support early-stage research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Explora BioLabs company profile →
WCCT Global
HQ: United States
Website
- Description: Provider of clinical trial services, research sites, and trial support for testing the safety and efficacy of new medications and medical devices, including participant recruitment, screening, and follow-up visits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WCCT Global company profile →
Reaction Biology
HQ: United States
Website
- Description: Provider of assay services and protein production for early-stage drug discovery, including biochemical, biophysical, electrophysiological and cell assays for high throughput screening (HTS); kinase and epigenetic assays; recombinant and custom protein production; 2D/3D cell-based assays; in vivo pharmacology (xenograft, immuno-oncology tumor models); and ADME & safety with in vitro safety screening, cardiac safety assessment, and in vivo PK/PD studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reaction Biology company profile →
International Vitamin
HQ: United States
Website
- Description: Provider of private label vitamin and nutritional supplements for store brands across retail channels, offering manufacturing, distribution, and contract services for vitamins, minerals, supplements, OTC and prescription products. Capabilities include soft gels (including vegetarian) and continuous-process tablets with Nutraglide coating, supported by R&D and regulatory expertise.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full International Vitamin company profile →
Ethos Health Communications
HQ: United States
Website
- Description: Provider of medical and marketing communications services, offering medical affairs to analyze complex data and landscapes; KOL data solutions to identify, map, and track thought leader influence; training, learning and development across the product life cycle; pharma marketing for commercialization, launch planning, and multichannel execution; digital opinion leader mapping in healthcare; and scientific communications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ethos Health Communications company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ProQinase
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ProQinase
2.2 - Growth funds investing in similar companies to ProQinase
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ProQinase
4.2 - Public trading comparable groups for ProQinase
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →